Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026951503> ?p ?o ?g. }
- W2026951503 endingPage "1470" @default.
- W2026951503 startingPage "1464" @default.
- W2026951503 abstract "After liver transplantation (LT), the management of recurrent hepatitis C virus (HCV) infections still remains a major challenge. In HCV genotype 1 patients not undergoing transplantation, the introduction of protease inhibitor (PI)-based regimens has increased the sustained virological response rate significantly. This pilot study investigated both the safety and efficacy of telaprevir (TVR)-based triple therapy in HCV-infected LT patients with a special emphasis on drug-drug interactions between immunosuppressants and PIs. Safety and efficacy data were gathered for 12 weeks for 9 HCV-infected LT patients who were treated with a combination of TVR, pegylated interferon, and ribavirin (RBV) in parallel with immunosuppressive drugs such as tacrolimus (TAC; n = 4), cyclosporine A (CSA; n = 4), and sirolimus (SIR; n = 1). Seven of the transplant patients completed the 12 weeks of triple therapy. At week 4, 4 of the patients were found to be HCV RNA-negative, and importantly, 8 were found to be negative at week 12. During the 12-week course of triple therapy, short-term measurements of immunosuppressant trough levels required individual dose reductions in all patients (CSA, 2.5-fold; SIR, 7-fold; and TAC, 22-fold). Furthermore, two-thirds of the patients exhibited hematological side effects requiring RBV dose reductions, the administration of erythropoietin, or even blood transfusions. In conclusion, this pilot study provides evidence showing that TVR-based triple therapy is effective within the first 4 to 12 weeks in LT patients suffering from HCV genotype 1 recurrence, and it also provides evidence showing that drug-drug interactions between TVR and immunosuppressants can be handled appropriately through the close monitoring of trough levels and adequate dosage adjustments." @default.
- W2026951503 created "2016-06-24" @default.
- W2026951503 creator A5009336896 @default.
- W2026951503 creator A5011943968 @default.
- W2026951503 creator A5029866965 @default.
- W2026951503 creator A5033706749 @default.
- W2026951503 creator A5034708142 @default.
- W2026951503 creator A5056667390 @default.
- W2026951503 creator A5083688499 @default.
- W2026951503 date "2012-12-01" @default.
- W2026951503 modified "2023-10-13" @default.
- W2026951503 title "Telaprevir‐based triple therapy in liver transplant patients with hepatitis C virus: A 12‐week pilot study providing safety and efficacy data" @default.
- W2026951503 cites W1966165262 @default.
- W2026951503 cites W1979815055 @default.
- W2026951503 cites W1986026306 @default.
- W2026951503 cites W1996157463 @default.
- W2026951503 cites W2013701172 @default.
- W2026951503 cites W2016940336 @default.
- W2026951503 cites W2019387287 @default.
- W2026951503 cites W2020021031 @default.
- W2026951503 cites W2025650160 @default.
- W2026951503 cites W2027545702 @default.
- W2026951503 cites W2029768048 @default.
- W2026951503 cites W2033667910 @default.
- W2026951503 cites W2035774969 @default.
- W2026951503 cites W2046658390 @default.
- W2026951503 cites W2052000792 @default.
- W2026951503 cites W2054043296 @default.
- W2026951503 cites W2056917506 @default.
- W2026951503 cites W2066422822 @default.
- W2026951503 cites W2107512529 @default.
- W2026951503 cites W2119764771 @default.
- W2026951503 cites W2125963799 @default.
- W2026951503 cites W2127685726 @default.
- W2026951503 cites W2128390124 @default.
- W2026951503 cites W2141214317 @default.
- W2026951503 cites W2143559032 @default.
- W2026951503 cites W2154574897 @default.
- W2026951503 cites W2155520529 @default.
- W2026951503 cites W2157961528 @default.
- W2026951503 cites W2160289288 @default.
- W2026951503 cites W2326003522 @default.
- W2026951503 doi "https://doi.org/10.1002/lt.23542" @default.
- W2026951503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22941516" @default.
- W2026951503 hasPublicationYear "2012" @default.
- W2026951503 type Work @default.
- W2026951503 sameAs 2026951503 @default.
- W2026951503 citedByCount "72" @default.
- W2026951503 countsByYear W20269515032013 @default.
- W2026951503 countsByYear W20269515032014 @default.
- W2026951503 countsByYear W20269515032015 @default.
- W2026951503 countsByYear W20269515032016 @default.
- W2026951503 countsByYear W20269515032017 @default.
- W2026951503 countsByYear W20269515032022 @default.
- W2026951503 crossrefType "journal-article" @default.
- W2026951503 hasAuthorship W2026951503A5009336896 @default.
- W2026951503 hasAuthorship W2026951503A5011943968 @default.
- W2026951503 hasAuthorship W2026951503A5029866965 @default.
- W2026951503 hasAuthorship W2026951503A5033706749 @default.
- W2026951503 hasAuthorship W2026951503A5034708142 @default.
- W2026951503 hasAuthorship W2026951503A5056667390 @default.
- W2026951503 hasAuthorship W2026951503A5083688499 @default.
- W2026951503 hasConcept C126322002 @default.
- W2026951503 hasConcept C203014093 @default.
- W2026951503 hasConcept C2522874641 @default.
- W2026951503 hasConcept C2776408679 @default.
- W2026951503 hasConcept C2776455275 @default.
- W2026951503 hasConcept C2776461080 @default.
- W2026951503 hasConcept C2776999253 @default.
- W2026951503 hasConcept C2778159067 @default.
- W2026951503 hasConcept C2779609443 @default.
- W2026951503 hasConcept C2780040827 @default.
- W2026951503 hasConcept C2909675724 @default.
- W2026951503 hasConcept C2911091166 @default.
- W2026951503 hasConcept C71924100 @default.
- W2026951503 hasConcept C90924648 @default.
- W2026951503 hasConceptScore W2026951503C126322002 @default.
- W2026951503 hasConceptScore W2026951503C203014093 @default.
- W2026951503 hasConceptScore W2026951503C2522874641 @default.
- W2026951503 hasConceptScore W2026951503C2776408679 @default.
- W2026951503 hasConceptScore W2026951503C2776455275 @default.
- W2026951503 hasConceptScore W2026951503C2776461080 @default.
- W2026951503 hasConceptScore W2026951503C2776999253 @default.
- W2026951503 hasConceptScore W2026951503C2778159067 @default.
- W2026951503 hasConceptScore W2026951503C2779609443 @default.
- W2026951503 hasConceptScore W2026951503C2780040827 @default.
- W2026951503 hasConceptScore W2026951503C2909675724 @default.
- W2026951503 hasConceptScore W2026951503C2911091166 @default.
- W2026951503 hasConceptScore W2026951503C71924100 @default.
- W2026951503 hasConceptScore W2026951503C90924648 @default.
- W2026951503 hasIssue "12" @default.
- W2026951503 hasLocation W20269515031 @default.
- W2026951503 hasLocation W20269515032 @default.
- W2026951503 hasOpenAccess W2026951503 @default.
- W2026951503 hasPrimaryLocation W20269515031 @default.
- W2026951503 hasRelatedWork W1574395574 @default.
- W2026951503 hasRelatedWork W1939121468 @default.
- W2026951503 hasRelatedWork W1968396938 @default.